Loandepot, Inc. current report, 11 August 2021

Business Context and Reporting Period

loanDepot, Inc. filed a Form 8-K reporting a material financing agreement entered into on August 11, 2021. Its indirect, majority-owned subsidiary, loanDepot.com, LLC, amended and restated a master repurchase agreement with UBS AG to finance residential mortgage loans.

Key Financial and Financing Terms

  • Facility: Uncommitted financing of up to $500.0 million.
  • Structure: loanDepot.com, LLC may sell residential mortgage loans to UBS AG and later repurchase them.
  • Interest rate: One-month LIBOR, or a successor rate, plus an applicable margin. The filing does not provide the applicable margin.
  • Expiration: April 19, 2022, unless extended or terminated earlier under the agreement.
  • Liquidity and debt: The agreement provides additional mortgage-loan financing capacity and creates a direct financial obligation when borrowings are outstanding. The filing does not state the amount drawn, outstanding debt, cash balance, revenue, profit, cash flow, or margins.

Material Changes, Outlook, and Risks

  • The agreement amends and restates a prior master repurchase agreement dated June 1, 2015, as amended.
  • Customary representations, warranties, covenants, funding conditions, events of default, and indemnities apply.
  • loanDepot.com, LLC must cure any margin deficit upon UBS AG’s request.
  • Upon an event of default, financing may be terminated and repurchase obligations may be accelerated and become immediately due at the repurchase price.
  • The filing provides no operating guidance, earnings outlook, management commentary, or quantified contingency exposure.

Investor Verification Checklist

  • Review Exhibit 10.1 for the complete covenant, margin, collateral, default, and termination provisions.
  • Verify the applicable interest-rate margin and any successor benchmark to one-month LIBOR.
  • Confirm actual borrowings and remaining availability under the $500.0 million uncommitted facility.
  • Assess potential margin-call and acceleration exposure, including the subsidiary’s ability to cure margin deficits.
  • Note that the report is dated August 11, 2021, while the signature is dated August 17, 2021, and verify the effective and filing dates.